All News

APR video gout cover

Gout

Jack Cush, MD

Dr. Jack Cush reviews Gout in this continuing series for Advanced Practice Rheum.

Read Article
manpower.cliff.shortage

Rheumatology Shortage Cliff in Australia & USA

Jack Cush, MD

Australia is facing a deepening rheumatology manpower crisis with direct parallels to the situation in the United States.

Read Article
APR Safety Video Cover

Safety of Biologics and Novel Agents

Jack Cush, MD

Dr. Jack Cush reviews safety of biologics and novel agents.

Read Article
healthcare workers

WSJ: Nurse Practitioner Is Now the Hottest Job in Healthcare

Jack Cush, MD

The Wall St. Journal has published a perspective on nurse practitioners (NP) and their very promising careers.

Read Article
RheumNow Podcast square

Quiz Talk (5.22.2026)

Jack Cush, MD

Dr. Jack Cush talks of birthdays, Quizzes and journal articles this week on the podcast.

Read Article
APR fibro video cover

Fibromyalgia

Jack Cush, MD

Dr. Jack Cush reviews fibromyalgia.

Read Article
RheumNow Podcast square

Influential Rheumatoid Factors (5.8.2026)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Read Article
APR SLE VIDEO COVER

Systemic Lupus Erythematosus

Jack Cush, MD

Dr. Cush reviews systemic lupus erythematosus.

Read Article
STEROIDS COVER

Steroids

Jack Cush, MD

In this Advanced Practice Rheum, Dr. Jack Cush reviews steroids.

Read Article
RheumNow Podcast square

Prescribing Lessons (4.17.2026)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.

Read Article
colon.Crohns.jpg

JAMA Guideline on the Management of Crohn Disease

Jack Cush, MD

JAMA has published a current Clinical Guidelines Synopsis on the Management of Crohn Disease (CD) in Adults.

Read Article
RheumNow Podcast square

What’s New PsA? (4.3.2026)

Jack Cush, MD

Dr. Jack Cush reviews the news and major articles from this week, including FDA safety warnings, reports from AAD, PsA trials.

Read Article
ILD.colors

Review: Rheumatoid Arthritis–Associated Interstitial Lung Disease

Jack Cush, MD

RA-ILD represents the most severe extra-articular manifestation of rheumatoid arthritis, affecting an estimated 1% of the adult population in the US and Northern Europe.

Read Article
WSJ: Nurse Practitioner Is Now the Hottest Job in Healthcare The Wall St. Journal has published a perspective on nurse practitioners (NP) and their very promising careers. https://t.co/YUasxB43ZO https://t.co/tkvKh0JEui

Links:

Dr. John Cush RheumNow ( View Tweet)
Advanced Practice Rheum: Fibromyalgia https://t.co/Wx09nPMA5n https://t.co/UAysDMGuFC

Links:

Dr. John Cush RheumNow ( View Tweet)
American Nurses Assoc. response to Dept of Education’s Final Rule on Graduate Loans for nurses: "..profoundly dismayed by DoE exclusion of nursing from....“professional degree” programs... this ignores the voices of over 245,000 nurses and nurse advocates https://t.co/WEYdiO9x4n https://t.co/3wxOwDBHVg

Links:

Dr. John Cush RheumNow ( View Tweet)
4/30/26 US Dept of Education finalized is rule on Grad loans "Reimagining and Improving Student Education (RISE)" that will markedly cut Federal Grad loans for nurses, nurse practitioner (NP) and physician associate (PA) training. https://t.co/kdm0ZLZfnL https://t.co/OGr3BEYga7

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR Backs the Provider Reimbursement Stability Act The ACR thanked lawmakers in the U.S. House of Representatives for introducing the bipartisan Provider Reimbursement Stability Act of 2025 (H.R. 8163), legislation designed to stabilize Medicare payments for physicians and https://t.co/15xU3DGD34
Dr. John Cush RheumNow ( View Tweet)
Psychiatrists have the highest Medicare opt-out rate (8% vs 1.2% MDs vs <3% Rheum), leading to a critical shortage of psychiatrists and more antipsychotic management to APRNs and PAs over the last decade. APPs Handle 40% of Antipsychotic Scripts https://t.co/wWnFcnXpRa https://t.co/WSQBEzvxgK

Links:

Dr. John Cush RheumNow ( View Tweet)
Spotty Medicare Coverage for Newer Rheumatoid Arthritis Meds Medicare coverage of targeted disease-modifying anti-rheumatic drugs (DMARDs) for RA -- both under Medicare Advantage and in separate Part D plans -- is likely to leave many patients wanting, researchers found. https://t.co/CW6gIHtnIw
Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×